EUVIMEDEUVIMED entdecken
Crossref

Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions

International Journal of Frontiers in Medicine · 2026 · 8 (1)

DOI: 10.25236/ijfm.2026.080103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Frontiers in Medicine, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions. International Journal of Frontiers in Medicine, 8(1). https://doi.org/10.25236/ijfm.2026.080103

Vancouver

Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions. International Journal of Frontiers in Medicine. 2026;8(1). doi:10.25236/ijfm.2026.080103

BibTeX
@article{euvimed2026,
  title = {Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions},
  journal = {International Journal of Frontiers in Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.25236/ijfm.2026.080103}
}
Kostenlos starten →